Novel lipid nanoparticles enhance oral bioavailability of curcumin in rats
DOI: 10.55421/ijpasr.2025.1206.001
A globally indexed, double-blind peer-reviewed publication advancing breakthroughs in pharmaceutical sciences, drug development, pharmacology, and translational research.
Original research, reviews, short communications, and case studies in pharmaceutical sciences. Fast-track peer review within 21 days. Indexed in Scopus, Web of Science, and PubMed Central.
IJPASR (International Journal of Pharmaceutical Sciences and Research) is an international peer-reviewed open-access journal published monthly, dedicated to disseminating high-quality research that bridges pharmaceutical sciences, biomedical innovation, and clinical practice.
Publish rigorous research advancing pharmaceutical sciences globally.
Drug discovery, pharmacology, formulation, biotech, clinical trials.
Authors and reviewers from 96 countries on six continents.
iThenticate plagiarism screening on every submission.
Comprehensive coverage of pharmaceutical and allied sciences.
Formulation, novel drug delivery, biopharmaceutics.
Mechanism of action, in-vivo/in-vitro studies.
Natural products, phytochemistry, ethnopharmacology.
Drug design, synthesis, QSAR, medicinal chemistry.
Therapeutics, pharmacovigilance, pharmaco-economics.
Antimicrobial research, vaccines, immunology.
Traditional, complementary & alternative medicine.
Safety pharmacology, regulatory toxicology.
Average 21-day decision cycle.
Indexed in 12+ international databases.
CC-BY 4.0 — free worldwide access.
Permanent CrossRef identifier.
COPE-compliant editorial standards.
Dedicated editorial assistance 24/5.
Upcoming deadlines for the December 2025 issue (Volume 12, Issue 06).
Author Guidelines| Event | Date | Status |
|---|---|---|
| Manuscript submission opens | Sep 01, 2025 | Open |
| Last date for submission | Nov 15, 2025 | Soon |
| Notification of acceptance | Nov 30, 2025 | Upcoming |
| Final camera-ready submission | Dec 05, 2025 | Upcoming |
| Publication date | Dec 15, 2025 | Upcoming |
“The peer-review process at IJPASR was rigorous yet remarkably fast. The editorial team is communicative and professional.”
“Open access publishing with IJPASR has significantly increased the visibility of our clinical research across Africa and Europe.”
“High editorial standards combined with careful indexing make IJPASR a trustworthy venue for serious pharmaceutical research.”
Everything authors and readers should know before submitting to IJPASR.
Reach out to our editorial team for any inquiry related to submissions, peer review, or partnerships.
Monthly digest of newly published articles, upcoming issues, and call for papers.